
The deal for Amplitude’s intravascular lithotripsy platform, which closed last week, included $435 million upfront and up to $400 million in milestone payments.

The deal for Amplitude’s intravascular lithotripsy platform, which closed last week, included $435 million upfront and up to $400 million in milestone payments.